BioSpace News Archive

Cyclolab and EpiPharma announced that the companies have signed an agreement to form a joint venture specialty pharmaceutical company to develop and commercialize novel conjugated Cyclodextrin – Peptide drug candidates for the treatment of debilitating CNS and Pulmonary diseases.

NANO-X IMAGING LTD (NASDAQ: NNOX) (“Nanox” or the “Company”), an innovative medical imaging technology company, today announces that Nanox’s Founder and Chief Executive Officer Ran Poliakine will deliver a company presentation and the leadership team will host investor 1x1 meetings during the Virtual 39th Annual J.P. Morgan Healthcare Conference,

Starton Therapeutics Inc. (“Starton” or the “Company”), a clinical stage biotechnology company powering continuous delivery of approved drugs in novel indications, announced today that it has selected a subcutaneous lenalidomide formulation as the lead formulation candidate for its continuous subcutaneous delivery system (STAR-LLD SC) for chronic lymphocytic leukemia (CLL) and other hematologic malignancies.

Inovalon (Nasdaq: INOV), a leading provider of cloud-based platforms empowering data-driven healthcare, today announced preliminary fourth quarter 2020 results highlighting the growing wave of previously reported new sales contracts now converting into revenue resulting in sequential top-line growth of 17% with continued new sales ACV acceleration to an all-time quarterly record of $93.5 million, up 27% YoY and 60% sequentially

Accolade, Inc. (NASDAQ: ACCD), which provides personalized, technology-enabled solutions that help people better understand, navigate, and utilize the healthcare system and their workplace benefits, will participate in the 39th Annual J.P. Morgan Healthcare Conference,

Spectral Medical Inc. (“Spectral” or the “Company”) (TSX: EDT), a late stage theranostic company advancing therapeutic options for sepsis and septic shock, as well as commercializing a new proprietary platform targeting the renal replacement therapy market through its wholly-owned subsidiary Dialco Medical Inc. (“Dialco”), today announced that it will be presenting at the H.C. Wainwright Virtual BioConnect Conference,

Full year 2020 revenue expected at the upper end of previously announced guidance range of $3.3M - $3.5M; greater than 40% growth over full year 2019 revenue of $2.4M

Intercept Pharmaceuticals, Inc., a biopharmaceutical company focused on the development and commercialization of novel therapeutics to treat progressive non-viral liver diseases, announced the appointment of Jared M. Freedberg as General Counsel and Secretary.

Milestone Scientific Inc., a leading developer of computerized drug delivery instruments that provides virtually painless and precise injections, reported that the Company’s Interim CEO, Leonard Osser, completed the sale of shares to cover the cost of his options and associated taxes, as previously announced on December 16, 2020.

Nemaura Medical, Inc. (NASDAQ: NMRD) (“Nemaura” or the “Company”), a medical technology company focused on developing and commercializing non-invasive wearable diagnostic devices and supporting personalized lifestyle coaching programs, today announces that CEO Faz Chowdhury, Ph.D. will present at the H.C. Wainwright Bioconnect 2021 Virtual Conference taking place January 11-14, 2021.